Signosis Overview
Company Headquarters: California, US
Founded: 2007
Company Working: Signosis is a molecular tool company that is focused on developing innovative and unique products for biomarker discovery and analysis in the areas of life science research, clinical application, and drug discovery. The company offers a wide selection of validated luciferase reporter cell lines that measure transcription factor activity as a read-out for various signaling pathways in many cell lines and provide a wide spectrum of over-expression stable cell lines, including a series of EGFR mutant over-expression stable cell lines. In addition to that, Signosis provides custom services in making custom assay kits and performing the assay and data analysis, generating custom stable cell lines to facilitate scientists’ research projects. It has distributors all around the world, including Germany, the UK, France, Sweden, Norway, Denmark, Finland, Italy, Australia, Egypt, Israel, Korea, Japan, Taiwan, and China.
Strategy
Signosis engages in providing efficient products to its customers to improve patient outcomes and enable precision health. It also aims to reposition itself as a worldwide provider with a broad spectrum of more sensitive, cost-effective, rapid assay products to target biomarkers such as disease-related proteins, mRNAs, microRNAs, epigenetic variations, and single-nucleotide polymorphism (SNP), with emphasis on a number of diseases including cancers, diabetes/obesity, and cardiovascular diseases.
